Kalonji

<h3> Absolute Contraindications of Kalonji </h3> <h4> Pregnancy - (may affect pregnancy or fertility)</h4> <ul> <li>🤰</li> <li>Recommendation: Avoid concentrated Kalonji oil or high-dose supplements during pregnancy; discuss with your obstetrician before use.</li> <li>Reasoning: Animal and some human studies show Kalonji extracts can influence uterine activity and reproductive hormones; animal contraceptive/antifertility effects and uterine-targeted actions suggest caution in pregnancy.</li> <li>Scientific_Study_Title: Post-coital contraceptive efficacy of the seeds of Nigella sativa in rats.</li> <li>Scientific_Study_Authors: M Hattori, et al.</li> <li>Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/7705872/</li> <li>Scientific_Study_Excerpt: <p>The referenced animal study tested hexane extracts of Nigella sativa seeds given orally to rats in the immediate post-coital period and observed prevention of pregnancy at the doses used. The authors reported antifertility and contraceptive effects in the treated animals, with activity localized to specific extract fractions. Although performed in rodents and not directly transferable to humans, these findings demonstrate biological effects on reproduction that justify avoiding high doses during human pregnancy.</p> <p>Separately, in vitro and animal experiments show volatile oils from Kalonji alter uterine smooth muscle responses, indicating that concentrated preparations can influence uterine contractility.</p> </li> </ul> <h4>Concurrent use with Warfarin or narrow-therapeutic anticoagulants</h4> <ul> <li>🩸</li> <li>Recommendation: Do NOT take Kalonji supplements concurrently with warfarin (or similar anticoagulants) without strict medical supervision and frequent INR monitoring; avoid self-adjusting doses.</li> <li>Reasoning: Laboratory data indicate thymoquinone inhibits CYP2C9 - an enzyme that metabolizes warfarin - and can alter warfarin clearance; this raises the risk of unpredictable anticoagulant levels and bleeding.</li> <li>Scientific_Study_Title: Potential food-drug interaction risk of thymoquinone with warfarin.</li> <li>Scientific_Study_Authors: Zhen Wang, Zhe Wang, Xiaoyu Wang, Xin Lv, Hang Yin, Lili Jiang, Yangliu Xia, Wei Li, Wenli Li, Yong Liu.</li> <li>Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/35921950/</li> <li>Scientific_Study_Excerpt: <p>In this in-vitro kinetics study the authors measured inhibition of warfarin 7-hydroxylation by thymoquinone and found competitive inhibition with an IC50 in the low micromolar range. Using the kinetic data, they modelled food-drug interaction risk and concluded that thymoquinone at sufficiently high intakes (and corresponding Nigella sativa supplement doses) could alter warfarin metabolism and thus warfarin blood levels. The study recommends caution when co-administering significant amounts of thymoquinone or concentrated Kalonji products with warfarin because of possible clinically meaningful interactions.</p> </li> </ul> <h4>Known allergy to Nigella sativa / seed oils - (contact or systemic allergy)</h4> <ul> <li>⚠️</li> <li>Recommendation: If you have a history of allergic skin reactions to seeds/oils or have developed a rash with Kalonji products, do not use it; seek allergy evaluation if reactions occur.</li> <li>Reasoning: Clinical reports and reviews document contact dermatitis and allergic reactions to topical and oral Kalonji preparations; allergy is a direct contraindication.</li> <li>Scientific_Study_Title: Black Seed (review) - safety and topical reactions discussed.</li> <li>Scientific_Study_Authors: Adam R. et al. (PubMed entry summarizing clinical findings)</li> <li>Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/30000936/</li> <li>Scientific_Study_Excerpt: <p>Clinical summaries and reviews note that topical and sometimes oral use of Nigella sativa products can cause allergic contact dermatitis in susceptible people. The review highlights that while most uses are well tolerated, case reports and patch-test positive reactions exist, and that no comprehensive human breastfeeding safety data are available. The review therefore recommends caution in those with skin or seed allergies.</p> <p>Because allergic reactions can be immediate and severe in predisposed individuals, prior documented allergy is an absolute contraindication to further exposure.</p> </li> </ul> <h4>Active bleeding disorder or thrombocytopenia (tendency to bleed)</h4> <ul> <li>🩹</li> <li>Recommendation: Avoid concentrated Kalonji supplements if you have an active bleeding disorder, very low platelets, or are preparing for surgery - discuss with your hematologist first.</li> <li>Reasoning: Preclinical studies show that Kalonji components can inhibit platelet aggregation and affect coagulation tests; in settings of bleeding risk this could worsen bleeding tendency.</li> <li>Scientific_Study_Title: Hematological studies on black cumin oil from the seeds of Nigella sativa L.</li> <li>Scientific_Study_Authors: M. Fukuda, K. et al.</li> <li>Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/11256491/</li> <li>Scientific_Study_Excerpt: <p>In animal and in-vitro assays the methanol-soluble fraction of black cumin oil inhibited arachidonic acid-induced platelet aggregation and altered coagulation parameters in dose-dependent ways. Specific isolated phenolic compounds from the oil showed potent antiplatelet activity, in some cases greater than standard comparators in the laboratory assay. These observations support clinical caution for patients with bleeding disorders or those on anticoagulant therapy when using concentrated Kalonji preparations.</p> </li> </ul> <h3> Relative Contraindications of Kalonji </h3> <h4> Diabetes with medications (risk of additive glucose-lowering)</h4> <ul> <li>📉</li> <li>Recommendation: If you are on insulin or other glucose-lowering medicines, use Kalonji only under medical supervision and monitor blood glucose frequently to avoid hypoglycemia.</li> <li>Reasoning: Multiple clinical trials and meta-analyses show Kalonji lowers fasting glucose and HbA1c; when combined with antidiabetic drugs it may increase the glucose-lowering effect.</li> <li>Scientific_Study_Title: Effect of Nigella sativa (black seed) supplementation on glycemic control: A systematic review and meta-analysis of clinical trials.</li> <li>Scientific_Study_Authors: S. Heshmati et al.</li> <li>Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/30873688/</li> <li>Scientific_Study_Excerpt: <p>This meta-analysis pooled randomized clinical trials and found statistically significant reductions in fasting plasma glucose, postprandial glucose and HbA1c in participants using Nigella sativa preparations versus controls. The authors note that N. sativa oil forms and thymoquinone-rich products were among the effective formulations, and caution that when used alongside conventional antidiabetic drugs the additive effects require dose monitoring to prevent hypoglycemia.</p> </li> </ul> <h4>Concurrent use with antihypertensive drugs (blood pressure lowering)</h4> <ul> <li>🫀</li> <li>Recommendation: If you take blood pressure medication, discuss Kalonji use with your prescriber and monitor blood pressure regularly - doses may require adjustment.</li> <li>Reasoning: Clinical trials report measurable reductions in systolic and diastolic blood pressure with Kalonji oil or seeds; combining it with antihypertensives could cause symptomatic hypotension in some people.</li> <li>Scientific_Study_Title: A randomized, double-blind, placebo-controlled clinical trial to evaluate the benefits of Nigella sativa seeds oil in reducing cardiovascular risks in hypertensive patients.</li> <li>Scientific_Study_Authors: H. Kaatabi, et al.</li> <li>Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/33957004/</li> <li>Scientific_Study_Excerpt: <p>In this randomized clinical trial hypertensive patients given Nigella sativa seed oil experienced significant reductions in systolic and diastolic blood pressure and improvements in lipid markers compared with placebo. Investigators observed measurable antihypertensive effects within weeks, supporting the need for blood pressure monitoring when Kalonji is used together with prescribed antihypertensives to avoid excessive lowering.</p> </li> </ul> <h4>Breastfeeding (insufficient human data; topical allergy risk)</h4> <ul> <li>🍼</li> <li>Recommendation: Avoid topical application to nipple/areola and avoid high-dose oral supplements while nursing unless advised by your healthcare provider; prefer food-level culinary use.</li> <li>Reasoning: There is limited human data on Kalonji excretion into breastmilk and case reports of topical allergic reactions; cautious avoidance of concentrated preparations is advised.</li> <li>Scientific_Study_Title: Black Seed - review of uses and safety (including breastfeeding notes).</li> <li>Scientific_Study_Authors: Adam R., et al.</li> <li>Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/30000936/</li> <li>Scientific_Study_Excerpt: <p>The review summarizes traditional uses and available safety data and explicitly notes there are no robust human studies on excretion of Nigella sativa components into breast milk. It also records topical allergic reactions and cautions that safety during breastfeeding is not established; therefore, concentrated oral or topical use near the breast should be avoided until more data are available.</p> </li> </ul>